rs397515340
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PM4_SupportingPP5_Very_Strong
The NM_152732.5(RSPH9):c.804_806del(p.Lys268del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.0000979 in 1,614,188 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00010 ( 1 hom. )
Consequence
RSPH9
NM_152732.5 inframe_deletion
NM_152732.5 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.66
Genes affected
RSPH9 (HGNC:21057): (radial spoke head component 9) This gene encodes a protein thought to be a component of the radial spoke head in motile cilia and flagella. Mutations in this gene are associated with primary ciliary dyskinesia 12. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PM2
?
Very rare variant in population databases, with high coverage;
PM4
?
Nonframeshift variant in NON repetitive region in NM_152732.5. Strenght limited to Supporting due to length of the change: 1aa.
PP5
?
Variant 6-43670917-GAGA-G is Pathogenic according to our data. Variant chr6-43670917-GAGA-G is described in ClinVar as [Pathogenic]. Clinvar id is 66994.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-43670917-GAGA-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RSPH9 | NM_152732.5 | c.804_806del | p.Lys268del | inframe_deletion | 5/5 | ENST00000372163.5 | |
RSPH9 | NM_001193341.2 | c.856_858del | p.Glu286del | inframe_deletion | 6/6 | ||
POLR1C | NM_001318876.2 | c.945+141651_945+141653del | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RSPH9 | ENST00000372163.5 | c.804_806del | p.Lys268del | inframe_deletion | 5/5 | 1 | NM_152732.5 | P1 | |
RSPH9 | ENST00000372165.8 | c.856_858del | p.Glu286del | inframe_deletion | 6/6 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.0000460 AC: 7AN: 152204Hom.: 0 Cov.: 33
GnomAD3 genomes
?
AF:
AC:
7
AN:
152204
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251438Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135906
GnomAD3 exomes
AF:
AC:
13
AN:
251438
Hom.:
AF XY:
AC XY:
9
AN XY:
135906
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000103 AC: 151AN: 1461866Hom.: 1 AF XY: 0.000103 AC XY: 75AN XY: 727238
GnomAD4 exome
AF:
AC:
151
AN:
1461866
Hom.:
AF XY:
AC XY:
75
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0000460 AC: 7AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74478
GnomAD4 genome
?
AF:
AC:
7
AN:
152322
Hom.:
Cov.:
33
AF XY:
AC XY:
5
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Primary ciliary dyskinesia 12 Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Sep 28, 2020 | This variant was reported in the homozygous state in multiple individuals presenting with pulmonary disease. A functional study has demonstrated that this variant causes immotile or abnormally beating cilia. RSPH9 c.804_806delGAA (rs909605187) is rare (<0.1%) in a large population dataset (gnomAD: 14/282846 total alleles; 0.005%; no homozygotes). This variant has been reported in ClinVar. RSPH9 c.804_806delGAA was found to segregate with disease in a large family. We consider this variant to be pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2009 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Apr 26, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 20, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 25, 2024 | - - |
Primary ciliary dyskinesia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Sep 06, 2022 | This variant, c.804_806del, results in the deletion of 1 amino acid(s) of the RSPH9 protein (p.Lys268del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs748432026, gnomAD 0.01%). This variant has been observed in individual(s) with primary ciliary dyskinesia (PMID: 19200523, 22384920, 23993197; Invitae). It has also been observed to segregate with disease in related individuals. This variant is also known as c.801_803delGAA. ClinVar contains an entry for this variant (Variation ID: 66994). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects RSPH9 function (PMID: 19200523). For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 24, 2022 | Published functional studies demonstrate a damaging effect consistent with a hypomorphic allele (Castleman et al., 2009); In-frame deletion of 1 amino acid in a non-repeat region.; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31772028, 19200523, 22384920, 23993197, 31130284, 31879361, 31589614, 33726816, 34401452) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at